The ERK/MAPK signaling pathway is also related to tumorigenesis and metastasis; increased ERK expression was found in various tumors, e.g., lung, breast, and colon cancers, and the MAPK signaling pathway modulates drug resistance 40, 41. Here, MAPK1 is linked to colonic neoplasm.